Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205663644> ?p ?o ?g. }
- W4205663644 endingPage "1424" @default.
- W4205663644 startingPage "1416" @default.
- W4205663644 abstract "Rationale: High-dose isoniazid is recommended in short-course regimens for multidrug-resistant tuberculosis (TB). The optimal dose of isoniazid and its individual contribution to efficacy against TB strains with inhA or katG mutations are unknown.Objectives: To define the optimal dose of isoniazid for patients with isoniazid-resistant TB mediated by inhA mutations.Methods: AIDS Clinical Trials Group A5312 is a phase 2A, open-label trial in which individuals with smear-positive pulmonary TB with isoniazid resistance mediated by an inhA mutation were randomized to receive isoniazid 5, 10, or 15 mg/kg daily for 7 days (inhA group), and control subjects with drug-sensitive TB received the standard dose (5 mg/kg/d). Overnight sputum cultures were collected daily. The 7-day early bactericidal activity (EBA) of isoniazid was estimated as the average daily change in log10 cfu on solid media (EBAcfu0-7) or as time to positivity (TTP) in liquid media in hours (EBATTP0-7) using nonlinear mixed-effects models.Measurements and Main Results: Fifty-nine participants (88% with cavitary disease, 20% HIV-positive, 16 with isoniazid-sensitive TB, and 43 with isoniazid-monoresistant or multidrug-resistant TB) were enrolled at one site in South Africa. The mean EBAcfu0-7 at doses of 5, 10, and 15 mg/kg in the inhA group was 0.07, 0.17, and 0.22 log10 cfu/ml/d, respectively, and 0.16 log10 cfu/ml/d in control subjects. EBATTP0-7 patterns were similar. There were no drug-related grade ≥3 adverse events.Conclusions: Isoniazid 10-15 mg/kg daily had activity against TB strains with inhA mutations similar to that of 5 mg/kg against drug-sensitive strains. The activity of high-dose isoniazid against strains with katG mutations will be explored next.Clinical trial registered with www.clinicaltrials.gov (NCT01936831)." @default.
- W4205663644 created "2022-01-25" @default.
- W4205663644 creator A5007514947 @default.
- W4205663644 creator A5020131744 @default.
- W4205663644 creator A5028037547 @default.
- W4205663644 creator A5045831486 @default.
- W4205663644 creator A5045935529 @default.
- W4205663644 creator A5048965341 @default.
- W4205663644 creator A5051030842 @default.
- W4205663644 creator A5059434182 @default.
- W4205663644 creator A5060359856 @default.
- W4205663644 creator A5061733161 @default.
- W4205663644 creator A5071465160 @default.
- W4205663644 creator A5075758950 @default.
- W4205663644 creator A5077848127 @default.
- W4205663644 creator A9999999999 @default.
- W4205663644 date "2020-06-01" @default.
- W4205663644 modified "2023-09-27" @default.
- W4205663644 title "Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial" @default.
- W4205663644 cites W1892455545 @default.
- W4205663644 cites W1964228023 @default.
- W4205663644 cites W1967983720 @default.
- W4205663644 cites W2007102363 @default.
- W4205663644 cites W2023355283 @default.
- W4205663644 cites W2034077454 @default.
- W4205663644 cites W2038014660 @default.
- W4205663644 cites W2052166920 @default.
- W4205663644 cites W2060626299 @default.
- W4205663644 cites W2072475014 @default.
- W4205663644 cites W2095717898 @default.
- W4205663644 cites W2102428789 @default.
- W4205663644 cites W2103327802 @default.
- W4205663644 cites W2114698696 @default.
- W4205663644 cites W2139097820 @default.
- W4205663644 cites W2151757899 @default.
- W4205663644 cites W2167629505 @default.
- W4205663644 cites W2170095570 @default.
- W4205663644 cites W2408003574 @default.
- W4205663644 cites W2608626794 @default.
- W4205663644 cites W2770976846 @default.
- W4205663644 cites W2791749037 @default.
- W4205663644 cites W2855009822 @default.
- W4205663644 cites W2911638797 @default.
- W4205663644 cites W2913839969 @default.
- W4205663644 cites W2921026546 @default.
- W4205663644 cites W2958443347 @default.
- W4205663644 cites W2989551129 @default.
- W4205663644 doi "https://doi.org/10.1164/rccm.201910-1960oc" @default.
- W4205663644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31945300" @default.
- W4205663644 hasPublicationYear "2020" @default.
- W4205663644 type Work @default.
- W4205663644 citedByCount "31" @default.
- W4205663644 countsByYear W42056636442020 @default.
- W4205663644 countsByYear W42056636442021 @default.
- W4205663644 countsByYear W42056636442022 @default.
- W4205663644 countsByYear W42056636442023 @default.
- W4205663644 crossrefType "journal-article" @default.
- W4205663644 hasAuthorship W4205663644A5007514947 @default.
- W4205663644 hasAuthorship W4205663644A5020131744 @default.
- W4205663644 hasAuthorship W4205663644A5028037547 @default.
- W4205663644 hasAuthorship W4205663644A5045831486 @default.
- W4205663644 hasAuthorship W4205663644A5045935529 @default.
- W4205663644 hasAuthorship W4205663644A5048965341 @default.
- W4205663644 hasAuthorship W4205663644A5051030842 @default.
- W4205663644 hasAuthorship W4205663644A5059434182 @default.
- W4205663644 hasAuthorship W4205663644A5060359856 @default.
- W4205663644 hasAuthorship W4205663644A5061733161 @default.
- W4205663644 hasAuthorship W4205663644A5071465160 @default.
- W4205663644 hasAuthorship W4205663644A5075758950 @default.
- W4205663644 hasAuthorship W4205663644A5077848127 @default.
- W4205663644 hasAuthorship W4205663644A9999999999 @default.
- W4205663644 hasConcept C114851261 @default.
- W4205663644 hasConcept C126322002 @default.
- W4205663644 hasConcept C142724271 @default.
- W4205663644 hasConcept C168563851 @default.
- W4205663644 hasConcept C2776301714 @default.
- W4205663644 hasConcept C2776967927 @default.
- W4205663644 hasConcept C2777768864 @default.
- W4205663644 hasConcept C2777975735 @default.
- W4205663644 hasConcept C2780687663 @default.
- W4205663644 hasConcept C2781069245 @default.
- W4205663644 hasConcept C71924100 @default.
- W4205663644 hasConcept C86803240 @default.
- W4205663644 hasConcept C89423630 @default.
- W4205663644 hasConcept C98274493 @default.
- W4205663644 hasConceptScore W4205663644C114851261 @default.
- W4205663644 hasConceptScore W4205663644C126322002 @default.
- W4205663644 hasConceptScore W4205663644C142724271 @default.
- W4205663644 hasConceptScore W4205663644C168563851 @default.
- W4205663644 hasConceptScore W4205663644C2776301714 @default.
- W4205663644 hasConceptScore W4205663644C2776967927 @default.
- W4205663644 hasConceptScore W4205663644C2777768864 @default.
- W4205663644 hasConceptScore W4205663644C2777975735 @default.
- W4205663644 hasConceptScore W4205663644C2780687663 @default.
- W4205663644 hasConceptScore W4205663644C2781069245 @default.
- W4205663644 hasConceptScore W4205663644C71924100 @default.
- W4205663644 hasConceptScore W4205663644C86803240 @default.
- W4205663644 hasConceptScore W4205663644C89423630 @default.